Search
News Archive
Categories
Neogen acquires VeroMara from GlycoMar Ltd.
Posted On: June 20, 2011Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd. Based in Oban, Scotland, VeroMara offers testing services to the shellfish and salmon aquaculture industries. VeroMara’s services include testing for shellfish toxins, general foodborne pathogens, including E. coli, noroviruses, and salmon husbandry.
VeroMara recorded revenues of approximately $800,000 (U.S.) in its most recently completed fiscal year. Terms of the acquisition were not disclosed. “The acquisition of VeroMara deepens Neogen’s advancement into the aquatic sciences,” said James Herbert, Neogen’s CEO and chairman. “VeroMara’s services are complementary and a nice fit with our existing product lines for the seafood industry, including one of our biggest food safety diagnostic products — our histamine tests for the tuna industry.
The VeroMara purchase also provides Neogen with key collaborative relationships with influential aquaculture partners, and increased access to important international markets. “Our new operation in Oban will work in close cooperation with our Neogen Europe headquarters in Ayr, Scotland, providing expanded products and services to a larger customer base,” Herbert continued. “Our sales and marketing operations in Ayr have the capability to expand VeroMara’s business to several other European countries.”
“The sale of our VeroMara testing service allows GlycoMar to focus on our core business — marine natural product research and development,” said Dr. Charles Bavington, GlycoMar’s managing director. “We are pleased to have VeroMara join Neogen, a company we respect as being one of the world leaders in food safety. This transition will guarantee uninterrupted quality service to our customers.”
Scotland’s VeroMara lands business in Iceland for implementing shellfish toxin rapid testing
Posted On: February 27, 2011VeroMara has been contracted by BioPol in Iceland to provide them with training, documentation, and support services for the implementation of shellfish toxin rapid testing. This will be the first time shellfish toxin testing has been conducted in Iceland, and will provide the basis for future monitoring and end product testing of shellfish produced in Icelandic waters.
BioPol is a marine biotechnology research station established on 1 September 2007. The implementation of shellfish toxin rapid tests is part of the EU FP7 MPP project.
VeroMara will provide training in all aspects of shellfish toxin testing using ELISA tests and Jellett rapid tests. VeroMara will also be providing supporting documentation and ongoing technical back up. VeroMara is a distributor in the UK & Eire for Biosense Laboratories and for Jellett Rapid testing. VeroMara also offers UKAS accredited testing services to the shellfish industry. VeroMara’s Manager commented, “we are delighted to be working with BioPol, which is our first contract outside the UK.
Scientists Uncovering Mode of Action of Certain Toxins that Accumulate in Seafood, Could Lead to New Screening Tests
Posted On: April 18, 2010Toxins released by certain microalgae can contaminate fish and shellfish which then become toxic to humans. Researchers from CNRS and CEA have, for the first time, identified the mechanisms of action of two of these toxins. They have shown how and why they cause neurological symptoms. These findings could provide a basis for the development of new tests to screen for these toxins. This work was published online this week on the website of the journal PNAS.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
